BioCentury | Dec 15, 2017
Financial News

Bellus Health raises C$20M in follow-on

...follow-on. The price values the company at C$45.4 million ($35.4 million). Bloom Burton, Cormark and Mackie Research Capital...
BioCentury | Jun 1, 2017
Financial News

Immunovaccine raises C$10M in bought deal

...at C$1.30 in a bought deal underwritten by Echelon Wealth Partners, National Bank Financial and Mackie Research Capital...
BioCentury | Dec 30, 2016
Financial News

Knight Therapeutics completes follow-on

...follow-on underwritten by GMP Securities, Cormark Securities, Bloom Burton, CIBC World Markets, Laurentian Bank Securities, Mackie Research Capital...
BioCentury | Dec 9, 2016
Financial News

Immunovaccine completes private placement

...in a private placement underwritten by a syndicate led by Echelon Wealth Partners and including Mackie Research Capital...
BioCentury | Dec 9, 2016
Financial News

Theratechnologies completes follow-on

...the sale of 5.3 million shares at C$3.10 to a syndicate of underwriters led by Mackie Research Capital...
BioCentury | May 23, 2016
Financial News

Immunovaccine completes follow-on

...million ($6.2 million) Units: 14.6 million Price: C$0.55 (unit) Shares after offering: 106.6 million Underwriters: Mackie Research Capital...
BioCentury | Feb 22, 2016
Financial News

Spectral Medical completes follow-on

...$7.2 million) Shares: 14.3 million Price: C$0.70 Shares after offering: 205.1 million Underwriters: Cormark Securities; Mackie Research Capital...
BioCentury | Aug 3, 2015
Financial News

Theratechnologies completes follow-on

...Units: 4 million Price: C$2.40 (unit) Shares after offering: 65 million Underwriters: Euro Pacific Canada; Mackie Research Capital...
BioCentury | Jan 5, 2015
Financial News

Knight Therapeutics completes follow-on

...Underwriters: GMP Securities; Cormark Securities; National Bank; Laurentian Bank Securities Inc.; Bloom Burton; Clarus Securities; Mackie Research Capital...
BioCentury | Dec 8, 2014
Financial News

Knight Therapeutics proposes private placement

...Underwriters: GMP Securities; Cormark Securities; National Bank; Laurentian Bank Securities Inc.; Bloom Burton; Clarus Securities; Mackie Research Capital...
Items per page:
1 - 10 of 14
BioCentury | Dec 15, 2017
Financial News

Bellus Health raises C$20M in follow-on

...follow-on. The price values the company at C$45.4 million ($35.4 million). Bloom Burton, Cormark and Mackie Research Capital...
BioCentury | Jun 1, 2017
Financial News

Immunovaccine raises C$10M in bought deal

...at C$1.30 in a bought deal underwritten by Echelon Wealth Partners, National Bank Financial and Mackie Research Capital...
BioCentury | Dec 30, 2016
Financial News

Knight Therapeutics completes follow-on

...follow-on underwritten by GMP Securities, Cormark Securities, Bloom Burton, CIBC World Markets, Laurentian Bank Securities, Mackie Research Capital...
BioCentury | Dec 9, 2016
Financial News

Immunovaccine completes private placement

...in a private placement underwritten by a syndicate led by Echelon Wealth Partners and including Mackie Research Capital...
BioCentury | Dec 9, 2016
Financial News

Theratechnologies completes follow-on

...the sale of 5.3 million shares at C$3.10 to a syndicate of underwriters led by Mackie Research Capital...
BioCentury | May 23, 2016
Financial News

Immunovaccine completes follow-on

...million ($6.2 million) Units: 14.6 million Price: C$0.55 (unit) Shares after offering: 106.6 million Underwriters: Mackie Research Capital...
BioCentury | Feb 22, 2016
Financial News

Spectral Medical completes follow-on

...$7.2 million) Shares: 14.3 million Price: C$0.70 Shares after offering: 205.1 million Underwriters: Cormark Securities; Mackie Research Capital...
BioCentury | Aug 3, 2015
Financial News

Theratechnologies completes follow-on

...Units: 4 million Price: C$2.40 (unit) Shares after offering: 65 million Underwriters: Euro Pacific Canada; Mackie Research Capital...
BioCentury | Jan 5, 2015
Financial News

Knight Therapeutics completes follow-on

...Underwriters: GMP Securities; Cormark Securities; National Bank; Laurentian Bank Securities Inc.; Bloom Burton; Clarus Securities; Mackie Research Capital...
BioCentury | Dec 8, 2014
Financial News

Knight Therapeutics proposes private placement

...Underwriters: GMP Securities; Cormark Securities; National Bank; Laurentian Bank Securities Inc.; Bloom Burton; Clarus Securities; Mackie Research Capital...
Items per page:
1 - 10 of 14